SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%
News
ISEE
--
0.00%
--
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Wire · 4d ago
IVERIC bio to Present at the Jefferies 2020 Healthcare Conference
IVERIC bio announced that Pravin Dugel, MD will present an overview of the Company at the Jefferies 2020 Virtual Healthcare Conference.
Business Wire · 05/27 12:00
Baker Brothers Snap Up These 3 Biotech Stocks
TipRanks · 05/26 15:43
Why IVERIC bio (ISEE) Stock Might be a Great Pick
Zacks · 05/21 13:40
Top Ranked Momentum Stocks to Buy for May 12th
Zacks · 05/12 15:02
New Strong Buy Stocks for May 11th
Zacks · 05/11 13:00
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/07 14:06
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week Highs May 5)
Benzinga · 05/06 14:36
IVERIC bio Q1 EPS $(0.280) Beats $(0.390) Estimate
IVERIC bio (NASDAQ:ISEE) reported quarterly losses of $(0.280) per share which beat the analyst consensus estimate of $(0.390) by 28.21 percent.
Benzinga · 05/06 11:27
IVERIC bio Reports First Quarter 2020 Operational Highlights and Financial Results
IVERIC bio announced financial and operating results for the fiscal quarter ended March 31, 2020 and provided a general business update.
Business Wire · 05/06 11:00
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IVERIC bio reported that it granted a newly hired, non-executive employee a non-statutory stock option to purchase 33,000 shares of common stock.
Business Wire · 05/04 12:00
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc.
Benzinga · 05/03 12:46
IVERIC bio to Report First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020
Business Wire · 04/28 13:00
IVERIC bio Announces Fast Track Designation from U.S. FDA for Zimura® for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Business Wire · 04/03 13:00
Iveric bio's Zimura Fast Track'd for macular degeneration
Seeking Alpha - Article · 04/03 12:24
IVERIC bio Announces Fast Track Designation From FDA For Zimura For Treatment Of Geographic Atrophy Secondary To Dry Age-Related Macular Degeneration
Benzinga · 04/03 12:14
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Wire · 04/02 13:00
IVERIC bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer
Business Wire · 03/23 21:01
New business chief at Iveric bio
Seeking Alpha - Article · 03/23 20:16
IVERIC bio Provides Update on the Initiation of the Second Pivotal Clinical Trial Enrollment for Zimura® in Patients With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
Business Wire · 03/18 12:00